Authors: Doronin, K Kuppuswamy, M Toth, K Tollefson, AE Krajcsi, P Krougliak, V Wold, WSM

Citation: K. Doronin et al., Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy, J VIROLOGY, 75(7), 2001, pp. 3314-3324

Authors: Tollefson, AE Toth, K Doronin, K Kuppuswamy, M Doronina, OA Lichtenstein, DL Hermiston, TW Smith, CA Wold, WSM

Citation: Ae. Tollefson et al., Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins, J VIROLOGY, 75(19), 2001, pp. 8875-8887

Authors: Kladney, RD Bulla, GA Guo, LS Mason, AL Tollefson, AE Simon, DJ Koutoubi, Z Fimmel, CJ

Citation: Rd. Kladney et al., GP73, a novel Golgi-localized protein upregulated by viral infection, GENE, 249(1-2), 2000, pp. 53-65

Authors: Doronin, K Toth, K Kuppuswamy, M Ward, P Tollefson, AE Wold, WSM

Citation: K. Doronin et al., Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein, J VIROLOGY, 74(13), 2000, pp. 6147-6155

Authors: Wold, WSM Doronin, K Toth, K Kuppuswamy, M Lichtenstein, DL Tollefson, AE

Citation: Wsm. Wold et al., Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic, CURR OP IM, 11(4), 1999, pp. 380-386

Authors: Wold, WSM Tollefson, AE

Citation: Wsm. Wold et Ae. Tollefson, Adenovirus E3 proteins: 14.7K, RID, and gp19K inhibit immune-induced cell death; Adenovirus death protein promotes cell death, SEMIN VIROL, 8(6), 1998, pp. 515-523